To Test, Or Not To Test – The COVID-19 Question

The research showed that countries with a higher health expenditure identify more positive cases and deaths.

Dr Cristina Isabel Ibarra-Armenta is a lecturer at the Autonomous University of Sinaloa and UNICAF University. Dr Moisés Alejandro Alarcon-Osuna is a lecturer at the University of Guadalajara, and a member of the Mexican System of National Researchers from CONACYT (National Council for Science and Technology). Their research focuses on econometrics, regional analysis, and policy and technology change. In a […]

Read More…

What can COVID-19 shutdowns teach us about reducing air pollution?

cartoon of masked people alongside a factory

The impact of COVID-19 on manufacturing, travel and the associated pollutant production has proved an unexpected opportunity for a global experiment for atmospheric scientists. Drs Jenny Stavrakou and Maite Bauwens at the Royal Belgian Institute for Space Aeronomy are experts in atmospheric modelling and interpretation of satellite measurements of air pollution. They have been exploring how COVID-related changes have affected […]

Read More…

COVID-19: An individualized treatment framework

Covid patient is fitted with a ventilator

The elderly are among those at greatest risk of serious infection and death from the coronavirus (COVID-19). By individualizing treatment for COVID-19 and its complications, a significant advance in medicine and improving care could be achieved. Dr Richard Aguilar and colleagues have developed the first known evidence-based recommendations for individualized treatment. These recommendations were derived from a preliminary review of […]

Read More…

COVID-19 and its variants

One of the defining issues of the COVID-19 pandemic and efforts to prevent its spread is inter-household transmission. Among the many policies and guidelines implemented, masks have been one of the most important and are now required wearing in the public spaces of many countries. But what if the masks we currently wear aren’t good enough? Researcher Devabhaktuni Srikrishna models […]

Read More…

The CEASE approach: A framework to tackle COVID-19 and other microbial threats

The CEASE approach

While the COVID-19 virus continues to spread in many countries worldwide, some researchers are investigating the implications of regularly using antimicrobial products and antibiotics, which could contribute to a concerning phenomenon known as antimicrobial resistance (AMR). Dr Teddie Rahube at Botswana International University of Science and Technology has recently developed CEASE, an approach that addresses some of the challenges associated […]

Read More…

Making an impact: How Altmetric tells researchers more about their work

Altmetric is the data and metrics tool that begins to measure the impact of research from the moment it is published.

Founded in 2011, Altmetric is the data and metrics tool that begins to measure the impact of research from the moment it is published, allowing researchers to see how, why and where their work is being used, discussed and expanded upon. CEO Kathy Christian told us how Altmetric works, why it is so important and who is already using it. […]

Read More…

Tracking how SARS-CoV-2 mutates around the world during COVID-19 pandemic

Tracking how SARS-CoV-2 mutates around the world during COVID-19 pandemic

The COVID-19 pandemic is an ongoing global health crisis caused by the SARS-CoV-2 strain of coronavirus. The SARS-CoV-2 virus mutates as it spreads, and monitoring these mutations and their distribution could provide information relevant for the treatment and control of the disease. Santiago Justo Arévalo (Ricardo Palma University, Peru) and his colleagues have analysed the progress of several mutations across […]

Read More…

Viral encephalitis and virus-mediated memory disorders

Prof Klein researches viral infections that target neurons.

Viral encephalitis is a debilitating consequence of viral infections: invasion of the brain by viruses causes an inflammation that, even months or years after recovery from the viral infection, can impair cognitive functions such as learning and memory. Prof Robyn S. Klein from Washington University School of Medicine has developed novel animal models and approaches to study virus-mediated memory disorders, […]

Read More…

Dihydromyricetin shows promise as anxiety disorder treatment

Jing Liang discovered that dihydromyricetin could have potential as a new treatment for anxiety disorders.

Anxiety disorders are one of the most common mental illnesses, and social isolation can be a major source of contributing stress. Medications to treat these disorders, such as benzodiazepines, are available; however, they come with a range of downsides. In a recent study in mice, Prof Jing Liang’s team at the USC School of Pharmacy in the US discovered that […]

Read More…

The Wolfson Foundation: 65 years of philanthropy

The foundation has created a special £10 million COVID-19 support fund for cultural organisations and health charities.

An independent grant-making charity based in Central London, The Wolfson Foundation has awarded some £1 billion to more than 14,000 projects in the UK from Cornwall to the Shetland Islands since its establishment in the 1950s. Chief Executive Paul Ramsbottom explains how academic decision-making is at the heart of what they do, and how they’ve adapted in the face of […]

Read More…

Thank you for expressing interest in joining our mailing list and community. Below you can select how you’d like us to interact with you and we’ll keep you updated with our latest content.

You can change your preferences or unsubscribe by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at audience@researchoutreach.org at any time and if you have any questions about how we handle your data, please review our privacy agreement.

Would you like to learn more about our services?

We use MailChimp as our marketing automation platform. By clicking below to submit this form, you acknowledge that the information you provide will be transferred to MailChimp for processing in accordance with their Privacy Policy and Terms.

Subscribe to our FREE PUBLICATION